BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 19172649)

  • 1. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
    Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Hua X; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
    Hum Brain Mapp; 2009 Sep; 30(9):2766-88. PubMed ID: 19172649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
    Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
    Neuroimage; 2009 Mar; 45(1 Suppl):S3-15. PubMed ID: 19041724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.
    Chou YY; Leporé N; Avedissian C; Madsen SK; Parikshak N; Hua X; Shaw LM; Trojanowski JQ; Weiner MW; Toga AW; Thompson PM;
    Neuroimage; 2009 Jun; 46(2):394-410. PubMed ID: 19236926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects.
    Apostolova LG; Morra JH; Green AE; Hwang KS; Avedissian C; Woo E; Cummings JL; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neuroimage; 2010 May; 51(1):488-99. PubMed ID: 20083211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated and manual hippocampal segmentation techniques: Comparison of results, reproducibility and clinical applicability.
    Hurtz S; Chow N; Watson AE; Somme JH; Goukasian N; Hwang KS; Morra J; Elashoff D; Gao S; Petersen RC; Aisen PS; Thompson PM; Apostolova LG
    Neuroimage Clin; 2019; 21():101574. PubMed ID: 30553759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Dinov ID; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Brain; 2006 Nov; 129(Pt 11):2867-73. PubMed ID: 17018552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
    Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
    Duara R; Loewenstein DA; Potter E; Appel J; Greig MT; Urs R; Shen Q; Raj A; Small B; Barker W; Schofield E; Wu Y; Potter H
    Neurology; 2008 Dec; 71(24):1986-92. PubMed ID: 19064880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.
    Hua X; Leow AD; Parikshak N; Lee S; Chiang MC; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neuroimage; 2008 Nov; 43(3):458-69. PubMed ID: 18691658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI.
    Wolz R; Heckemann RA; Aljabar P; Hajnal JV; Hammers A; Lötjönen J; Rueckert D;
    Neuroimage; 2010 Aug; 52(1):109-18. PubMed ID: 20382238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects.
    Madsen SK; Ho AJ; Hua X; Saharan PS; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neurobiol Aging; 2010 Aug; 31(8):1312-25. PubMed ID: 20538376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.
    Hua X; Lee S; Yanovsky I; Leow AD; Chou YY; Ho AJ; Gutman B; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Neuroimage; 2009 Dec; 48(4):668-81. PubMed ID: 19615450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.
    Bartel F; Visser M; de Ruiter M; Belderbos J; Barkhof F; Vrenken H; de Munck JC; van Herk M;
    Neuroimage Clin; 2019; 23():101902. PubMed ID: 31233953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging predictors of cognition in mild cognitive impairment.
    van de Pol LA; Korf ES; van der Flier WM; Brashear HR; Fox NC; Barkhof F; Scheltens P
    Arch Neurol; 2007 Jul; 64(7):1023-8. PubMed ID: 17620494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly.
    Wolf H; Grunwald M; Kruggel F; Riedel-Heller SG; Angerhöfer S; Hojjatoleslami A; Hensel A; Arendt T; Gertz H
    Neurobiol Aging; 2001; 22(2):177-86. PubMed ID: 11182467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: the Tajiri Project.
    Yamaguchi S; Meguro K; Shimada M; Ishizaki J; Yamadori A; Sekita Y
    Neuroradiology; 2002 Jan; 44(1):43-8. PubMed ID: 11942499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
    Liu G; Liu C; Qiu A;
    Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.
    Leung KK; Barnes J; Ridgway GR; Bartlett JW; Clarkson MJ; Macdonald K; Schuff N; Fox NC; Ourselin S;
    Neuroimage; 2010 Jul; 51(4):1345-59. PubMed ID: 20230901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
    Whitwell JL; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
    Brain; 2007 Jul; 130(Pt 7):1777-86. PubMed ID: 17533169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.